Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
22.34
-0.10 (-0.45%)
At close: Feb 21, 2025, 4:00 PM
22.33
-0.01 (-0.04%)
After-hours: Feb 21, 2025, 5:02 PM EST
Genmab Revenue
In the year 2024, Genmab had annual revenue of 21.53B DKK with 30.67% growth. Genmab had revenue of 6.44B in the quarter ending December 31, 2024, with 35.34% growth.
Revenue (ttm)
21.53B DKK
Revenue Growth
+30.67%
P/S Ratio
4.72
Revenue / Employee
8,038,088 DKK
Employees
2,678
Market Cap
14.09B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.53B | 5.05B | 30.67% |
| Dec 31, 2023 | 16.47B | 1.97B | 13.57% |
| Dec 31, 2022 | 14.51B | 6.09B | 72.33% |
| Dec 31, 2021 | 8.42B | -1.69B | -16.75% |
| Dec 31, 2020 | 10.11B | 4.75B | 88.43% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
GMAB News
- 1 day ago - EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma - GlobeNewsWire
- 2 days ago - Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference - GlobeNewsWire
- 3 days ago - Genmab: Positive 2025 Outlook, Johnson & Johnson's Decision Coming Soon - Seeking Alpha
- 7 days ago - Genmab A/S (GMAB) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 8 days ago - Notice to Convene the Annual General Meeting of Genmab A/S - GlobeNewsWire
- 9 days ago - Genmab Files Annual Report with the U.S. Securities and Exchange Commission - GlobeNewsWire
- 9 days ago - Genmab Publishes 2024 Annual Report - GlobeNewsWire
- 4 weeks ago - Grant of Restricted Stock Units and Warrants to Employees in Genmab - GlobeNewsWire